RETA RETA

Reata Pharmaceuticals Stock Price

29.01
1.21 (4.35%)
Upgrade to Real-Time
Regular Market
29.01
Volume 185,709
Bid Price 29.01
Ask Price 29.07
News -
Day High 29.45

Low
20.235

52 Week Range

High
153.41

Day Low 27.11
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Reata Pharmaceuticals Inc RETA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.21 4.35% 29.01 11:25:56
Open Price Low Price High Price Close Price Prev Close
28.38 27.11 29.45 27.80
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,998 185,709 $ 28.27 $ 5,249,148 - 20.235 - 153.41
Last Trade Time Type Quantity Stock Price Currency
11:25:55 5 $ 29.04 USD

Period:

Draw Mode:

Reata Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.06B 36.46M 20.30M $ 11.49M $ - -8.18 -3.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 519.53k 1.10%

more financials information »

Reata Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RETA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.0129.4525.8427.73559,8091.003.57%
1 Month26.5829.4520.23525.56508,0062.439.14%
3 Months30.9040.6420.23530.68629,328-1.89-6.12%
6 Months82.0095.344720.23532.60820,558-52.99-64.62%
1 Year126.85153.4120.23556.26557,679-97.84-77.13%
3 Years87.26257.96520.235104.83429,256-58.25-66.75%
5 Years26.79257.96519.3191.28353,5092.228.29%

Reata Pharmaceuticals Description

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.


Your Recent History
NASDAQ
RETA
Reata Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.